Suggestions
Alexandra Sifferlin
Health & Science editor at The New York Times Opinion
Alexandra Sifferlin is a prominent health and science journalist who currently serves as the Health and Science Editor for The New York Times Opinion desk.14 With a strong background in science communication, Sifferlin has established herself as a respected voice in the field of health and science journalism.
Career Highlights
Current Role:: Sifferlin joined The New York Times Opinion desk as the health and science editor on February 16, 2021.4 In this position, she oversees health and science-related content for the Opinion section of the newspaper.
Previous Experience::
- Deputy Editor at Elemental, a science-backed health and wellness publication on Medium45
- Contributing editor to OneZero5
- Time magazine, where she likely covered health and science topics
Writing and Publications
Sifferlin is currently working on a book titled "Undiagnosed," which is set to be published by Viking Books.3 This project demonstrates her continued commitment to exploring complex health topics and sharing them with a wider audience.
Education and Professional Network
Alexandra Sifferlin received her education from Northwestern University.2 She has built a strong professional network, with over 500 connections on LinkedIn.2 Her LinkedIn profile can be found under the username alexandra-sifferlin-baba3a29.
Online Presence
Sifferlin maintains an active online presence, sharing her work and insights through various platforms:
Through her role at The New York Times and her various writing projects, Alexandra Sifferlin continues to contribute significantly to public understanding of health and science issues, particularly in the context of opinion and analysis.
Highlights
Have you or someone you know worked as general counsel for a hospital or hospital system (or similar)? If so, please message me!
World Health Organization director general Dr. Tedros on the Covid-19 situation worldwide:
"We face the very real possibility of affluent countries administering variant-blocking boosters to already vaccinated people when many countries will still be scrounging for enough vaccines to cover their most-at-risk groups...This is unacceptable."
